Literature DB >> 24001014

De novo mutations in the cone-rod homeobox gene associated with leber congenital amaurosis in Chinese patients.

Xuan Zou1, Fengxia Yao, Xiaofang Liang, Fei Xu, Hui Li, Ruifang Sui, Fangtian Dong.   

Abstract

BACKGROUND: The cone-rod homeobox (CRX) gene plays an important role in photoreceptor development. Recently, mutant alleles of the CRX gene have been associated with autosomal dominant Leber congenital amaurosis (LCA) and cone-rod dystrophy. The purpose of this study was to analyze the CRX mutations in a cohort of Chinese patients with LCA or early-onset severe retinal dystrophy (EOSRD) and to provide the clinical features of these patients.
METHODS: Patients with LCA or EOSRD were enrolled from 2003 to 2012. Detailed ocular examinations including optical coherence tomography (OCT) and standardized electrophysiology were performed. Genomic DNA was isolated with standard methods of genetic diagnosis. All three exons of CRX were amplified with PCR and screened for mutations through direct DNA sequencing. A total of 200 unrelated healthy Chinese subjects were screened to exclude nonpathogenic polymorphisms. Offspring-parent relationship was tested to confirm de novo mutation.
RESULTS: A total of 109 probands from 109 unrelated families were selected for mutation screening of the CRX gene. Two individuals with LCA were confirmed to carry de novo CRX mutations c.421delT (p.Ser141Pro fsX46) and c.571delT (p.Tyr191Met fsX3), respectively. The daughter of Case 1 also carried the same CRX mutation (c.421delT) and had LCA symptoms. Pigmentary retinopathy in the peripheral retina and macular atrophy were observed in the two probands. Macular atrophy without normal lamination structure was the retina phenotype under OCT.
CONCLUSIONS: Two de novo mutations in CRX were found in Chinese patients with LCA. The CRX mutation might create a dominantly inherited trait.

Entities:  

Keywords:  Cone-rod homeobox; Leber congenital amaurosis; gene mutation

Mesh:

Substances:

Year:  2013        PMID: 24001014     DOI: 10.3109/13816810.2013.827219

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  7 in total

1.  Histopathology of the Retina from a Three Year-Old Suspected to Have Joubert Syndrome.

Authors:  V L Bonilha; M E Rayborn; B A Bell; M J Marino; E I Traboulsi; S A Hagstrom; J G Hollyfield
Journal:  Austin J Clin Ophthalmol       Date:  2015-09-21

2.  Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population.

Authors:  Shiyuan Wang; Qi Zhang; Xiang Zhang; Zhaoyang Wang; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-16       Impact factor: 3.117

Review 3.  Mechanisms of blindness: animal models provide insight into distinct CRX-associated retinopathies.

Authors:  Nicholas M Tran; Shiming Chen
Journal:  Dev Dyn       Date:  2014-06-27       Impact factor: 3.780

4.  Clinical exome sequencing facilitates the understanding of genetic heterogeneity in Leber congenital amaurosis patients with variable phenotype in southern India.

Authors:  Sriee Viswarubhiny; Rupa Anjanamurthy; Ayyasamy Vanniarajan; Devarajan Bharanidharan; Vijayalakshmi Perumalsamy; Periasamy Sundaresan
Journal:  Eye Vis (Lond)       Date:  2021-05-06

Review 5.  Review of Ocular Manifestations of Joubert Syndrome.

Authors:  Stephanie F Wang; Tia J Kowal; Ke Ning; Euna B Koo; Albert Y Wu; Vinit B Mahajan; Yang Sun
Journal:  Genes (Basel)       Date:  2018-12-04       Impact factor: 4.096

Review 6.  Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid.

Authors:  Di Huang; Sue Fletcher; Steve D Wilton; Norman Palmer; Samuel McLenachan; David A Mackey; Fred K Chen
Journal:  Vision (Basel)       Date:  2017-09-01

7.  CrxRdy Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis.

Authors:  Laurence M Occelli; Nicholas M Tran; Kristina Narfström; Shiming Chen; Simon M Petersen-Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.